Militello John reported grant involving 80,000 shares of IRulya Therapeutics Inc. at $0.00 for $0 on Nov 9, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Financial Officer
Chief Financial Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
80,000Common Stotck
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
80,000Direct
Trade date
Nov 9, 2026Grant
Filed
Nov 12, 2026, 4:10 PM ET3-day reporting delay
Accession
0001662170-26-000004Code A · Transaction 398799
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

IRLA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IRLA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's 2026 Equity Incentive Plan (the "2026 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock on the vesting date of the RSUs. 25% of the RSUs vest on the last day of the calendar quarter in which the first anniversary of the Vesting Commencement Date of July 8, 2026 occurs and an additional 6.25% of the RSUs vest at the end of each subsequent calendar quarter thereafter, subject to the Reporting Person's Continued Service (as defined in the 2026 Plan) with the Issuer as of each such vesting date.